Cargando…
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
Doxorubicin (DOX) has been recognized as one of the most effective chemotherapies and extensively used in the clinical settings of human cancer. However, DOX-mediated cardiotoxicity is known to compromise the clinical effectiveness of chemotherapy, resulting in cardiomyopathy and heart failure. Rece...
Autores principales: | Maneechote, Chayodom, Chattipakorn, Siriporn C., Chattipakorn, Nipon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143663/ https://www.ncbi.nlm.nih.gov/pubmed/37111670 http://dx.doi.org/10.3390/pharmaceutics15041182 |
Ejemplares similares
-
Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury
por: Maneechote, Chayodom, et al.
Publicado: (2017) -
Effects of doxorubicin‐induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions
por: Osataphan, Nichanan, et al.
Publicado: (2020) -
Targeting necroptosis as therapeutic potential in chronic myocardial infarction
por: Piamsiri, Chanon, et al.
Publicado: (2021) -
Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways
por: Khuanjing, Thawatchai, et al.
Publicado: (2023) -
Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
por: Attachaipanich, Tanawat, et al.
Publicado: (2023)